AMR Trends in Africa: Data from a Retrospective Analysis of 14 Countries

Select Content Type
Briefs
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
AMR_thumbnail
Detail Image
AMR_detailed
Book Detail
Actions
Download in App
Promotional Categories
Featured
Countries of release
Angola
Central African Republic (CAR)
Democratic Republic of the Congo (DRC)
Ghana
India
Kenya
Nigeria
UAE
Zambia
IS_Ebsco
false
Description

A 2025 study in PLOS Medicine analyzed AMR data from 205 labs across 14 African countries (2016–2019), offering the most comprehensive regional snapshot to date. The findings reveal wide variation in resistance rates, with higher AMR linked to older age, male sex, and hospitalization. 

Key limitations such as inconsistent testing and limited clinical data underscore the urgent need for stronger lab capacity and surveillance to address the AMR threat in Africa.

To read the full article, click here

Published Date